• Home
  • About
    • Group CEO
    • Management Team
    • Supervisory Board
    • Scientific Advisory Board
    • Affiliates
    • R&D Partnerships
    • Distributors
    • Quality Standards
    • Location
  • Services
    • Proteomics
    • Genomics Transcriptomics
    • Flow Cytometry
    • Assay Development
    • Monoclonal Antibodies
    • Biobanking
    • Biomarker Data Analyses
    • Biomarker Regulatory Services
  • Products
    • EASYCOV
    • FIMICS
    • BIOPRED
    • IVD Products
    • ELISA Kits
    • Recombinant Proteins
    • Monoclonal Abodies
    • Clinical Samples
    • Your Customized Kit
  • R&D
  • Quality
  • Investors
    • Financial Management
    • Financial Data
    • Shareholders
  • Media
    • Press Releases
    • Media News
    • Newsletters
    • Posts
    • All Media
  • Careers
Contact
Firalis
  • Home
  • About
  • Services
  • Products
  • R&D
  • Quality
  • Investors
  • Media

Media News

Le test Covid-19 qui fait saliver le monde !

Parution de Firalis dans le magazine régional Point Eco Alsace.

10.03.2021

Firalis and EasyCOV on DNA

Firalis and EasyCOV on DNA

Firalis and the EasyCOV test are mentioned on an article published by the "DNA" (Les Dernières Nouvelles d'Alsace).

10.05.2020

Firalis on "Point Eco Alsace"

Biomarkers for Future's Medicines

13.03.2020

Firalis on « Les Echos »

13.03.2020

Amoneta on "DNA"

Amoneta Diagnostics' project to develop an early detection kit for Alzheimer's Diagnostic is awarded by the Alzheimer’s Drug Discovery Foundation, with a grant of up to of USD 2 millions.

13.03.2020

Article on "Alzheimer's algorithms"

19.09.2019

Article on "Western Europe Team"

21.08.2019

Article on "The Korean & Japanese market"

28.05.2019

Article on "The Pacific Consortium"

20.03.2019

Article on "ADDIA’s algorithms"

16.01.2019

Article on "Amoneta Diagnostics"

22.11.2018

Article on "The BIOPRED panel"

26.09.2018

Article on "Illumina certification"

20.12.2017

Article on "BIO-Europe Spring 2017"

05.04.2017

Article on "Biomarkers Congress in Manchester !"

01.03.2017

Article on "Olink certification service"

23.02.2017

Load More

Follow us on

Contact Firalis

Firalis Group

© Copyright 2020 all rights reserved. 

The company logos, products and service marks are trademarks or registered trademarks of Firalis.

-----------------------------------------------------------------------------------------------------------------------

Information addressed to health professionals. The products presented on this site are for professional use only and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

-----------------------------------------------------------------------------------------------------------------------

Headquarter : 17 Rue du Fort 68330 Huningue FRANCE

follow Firalis on
Linkedin

EasyCOV

The first Covid-19 Rapid Salivary Test

99% Specific & 86% Sensitive

 

  • No more painful NP Swabs
  • No need for a Laboratory
  • Since 22/01/2021 officially equal to an RT-PCR Test!
  • Sample to Result time only 40 Minutes!
  • Result in an instant thanks to RT-LAMP Technology

 

LEARN MORE &

GET YOUR QUOTATION NOW !

EasyCOV

The first Covid-19 Rapid Salivary Test

99% Specific & 86% Sensitive

 

  • No more painful NP Swabs
  • No need for a Laboratory
  • Since 22/01/2021 officially equal to an RT-PCR Test!
  • Sample to Result time only 40 Minutes!
  • Result in an instant thanks to RT-LAMP Technology

 

LEARN MORE &

GET YOUR QUOTATION NOW !